- Total income
- ₹6,250 Cr
- Profit
- ₹1,437 Cr
About Colgate-Palmolive
Colgate-Palmolive is a publicly listed company based in Mumbai (India). Colgate-Palmolive is engaged in manufacturing oral care and household products. It operates on a Direct-to-Consumer (D2C) and Reseller / Distribution model. Colgate-Palmolive has completed 1 acquisition, including unknown. Its Indian entity Colgate-Palmolive (India) Limited reported revenue of βΉ6,124 Cr. Colgate-Palmolive offers products and services including Colgate Toothpaste and Colgate Toothbrush. Its focus areas include Consumer Goods, Personal Care and Oral Hygiene. Its competitors include Perfora, Salt Oral Care and Spicta; 2 of its 3 listed competitors have raised funding.
Company details
Colgate-Palmolive is involved in the production and distribution of oral care, personal care, and household products. The company operates globally, focusing on innovative solutions for consumer needs. Sectors served include health and hygiene with a commitment to sustainability. Various brands under its portfolio cater to diverse markets. Community impact initiatives like Bright Smiles, Bright Futures are supported. Environmental preservation and diversity inclusion are prioritized in operations.
Colgate-Palmolive is ranked #381 on the Fortune India 500 (2025) and #122 on the Fortune MNC 500 India (2026).
Recognitions & Rankings of Colgate-Palmolive
- Total income
- ₹6,250 Cr
- Profit
- ₹1,437 Cr
- Headquarters Mumbai, India
- Stage Public
- SectorsConsumer
- Phoneβ’β’β’β’ β’β’β’β’
- Website colgatepalmolive.co.in
- Social LinkedIn Instagram YouTube
- Legal Name Colgate-Palmolive Company
- Date of Incorporation 23 Sep, 1937
- Market Cap₹43,561 Cr
COLPAL · NSE
- Share Price₹1,629.80
+1.76% today
- Revenue₹6,035 Cr
FY 2025-26 · -0.1% YoY
- EBITDA₹1,845 Cr
Margin 30.6%
- Net Profit₹1,344 Cr
FY 2025-26 · -6.4% YoY
- P/E (TTM)30.9x
P/B 40.4x
- ROE81.6%
ROCE 104.1%
- Debt / Equity0.03
Interest cover 0.2x
- Investments & Acquisitions
Associated legal entities of Colgate-Palmolive
Colgate-Palmolive operates through Colgate-Palmolive (India) Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Colgate-Palmolive (India) Limited Listed CIN L24200MH1937PLC002700 | Active | 23 Sep 1937 | Mumbai, Maharashtra | ₹6,124 Cr | 2,391 | 11 | View details |
Products & Services of Colgate-Palmolive
Colgate-Palmolive offers a comprehensive portfolio of products and services, including Colgate Toothpaste and Colgate Toothbrush.
Toothpaste products are offered for oral hygiene maintenance.
Toothbrushes are provided for effective dental cleaning purposes.
Apps and channels of Colgate-Palmolive
its YouTube channel Colgate-Palmolive Company has 135K subscribers.
Board of directors of Colgate-Palmolive (India) Limited (Colgate-Palmolive)
Colgate-Palmolive (India) Limited is the primary company behind Colgate-Palmolive. The board of Colgate-Palmolive (India) Limited currently have 8 directors; the longest-serving is Jacob Sebastian Madukkakuzy, appointed in 2016. 25 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Jacob Sebastian Madukkakuzy DIN 07645510 | Whole-time director | 28 Oct 2016 | 10 yrs | Colgate-Palmolive (India) Limited |
| Sukanya Kripalu DIN 06994202 | Director | 01 Jun 2018 | 8 yrs 4 mo | Colgate-Palmolive (India) Limited |
| Mukul Vinayak Deoras DIN 02869422 | Director | 01 Sep 2018 | 8 yrs 1 mo | Colgate-Palmolive (India) Limited |
| Gopika Pant DIN 00388675 | Director | 21 May 2020 | 6 yrs 5 mo | Colgate-Palmolive (India) Limited |
| Sekhar Natarajan DIN 01031445 | Director | 21 May 2020 | 6 yrs 5 mo | Colgate-Palmolive (India) Limited |
| Prabha Narasimhan DIN 08822860 | Managing Director | 01 Sep 2022 | 4 yrs 1 mo | Colgate-Palmolive (India) Limited |
| Indu Bhushan DIN 09302960 | Director | 26 Jul 2023 | 3 yrs 3 mo | Colgate-Palmolive (India) Limited |
| Sanjay Gupta DIN 05100297 | Director | 22 Jan 2024 | 2 yrs 9 mo | Colgate-Palmolive (India) Limited |
People of Colgate-Palmolive
136 people are tracked at Colgate-Palmolive (12 in leadership, 124 in team).
| Name | Role | Group |
|---|---|---|
Apala Sen | Head Of Innovation & Member Of Executive Committee | Leadership |
Sujata Nairi | Associate Director - Commercial And Investor Relations | Leadership |
Sonal Baid | Director- Sales And Marketing HR | Leadership |
Ruchir Bhatnagar | Executive Vice President, Customer Development | Leadership |
| Managing Director and Chief Executive Officer | Leadership | |
Roney Eapen | Head Of Insights And Analytics - India | Leadership |
Jacob | Wholetime Director & CFO | Leadership |
Swati Agarwal | Sr. Director R&d India Global Technology Center | Leadership |
Badal Choudhary | Director CD Transformation (centre Of Excellence) | Leadership |
Johnny Amerling | Director | Leadership |
Anubhuti Nath Santani | Senior Director - Customer Development, South & West India | Leadership |
Mriganki Tyagi | Director E-commerce | Leadership |
Dhanya Shetty | Associate Analyst 1 | Team |
Ashwini Pawar | Associate Analyst | Team |
Ajitosh A. | Assistant Manager Business Analytics | Team |
Aditya Walkhede | Associate Distributor Analyst (third Party) | Team |
Vaishnavi Navane | Senior Analyst | Team |
Swati Attre | Technical Analyst | Team |
Ankur Kumar Pandey | Customer Development Executive | Team |
Rajat Prakash Mishra | Innovation Project Manager | Team |
116 more people are available in the full profile.
Complete people profiles for Colgate-Palmolive
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Colgate-Palmolive
Colgate-Palmolive is a publicly listed company on the NSE with ticker symbol COLPAL in India, operating in the FMCG sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- Listed onNSE: COLPAL
- Listed entityColgate-Palmolive (India) Limited
- Exchange sectorFMCG
Financials of Colgate-Palmolive
Exchange-reported figures of Colgate-Palmolive (India) Limited, the listed company behind Colgate-Palmolive (NSE: COLPAL).
Financial Highlights
FY 2025-26 Β· StandaloneRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 6,035 | 6,040 | 5,680 | 5,226 | 5,100 | 4,841 | 4,525 |
| Revenue growth | -0.1% | +6.3% | +8.7% | +2.5% | +5.3% | +7.0% | - |
| EBITDA | 1,845 | 1,958 | 1,881 | 1,536 | 1,566 | 1,510 | 1,202 |
| EBITDA margin | +30.6% | +32.4% | +33.1% | +29.4% | +30.7% | +31.2% | +26.6% |
| Profit before tax | 1,784 | 1,930 | 1,781 | 1,410 | 1,409 | 1,350 | 1,043 |
| Net profit | 1,344 | 1,436 | 1,338 | 1,055 | 1,078 | 1,036 | 816 |
| Net profit margin | +22.3% | +23.8% | +23.6% | +20.2% | +21.2% | +21.4% | +18.0% |
| EPS (βΉ) | 48.72 | 52.82 | 48.66 | 38.50 | 39.65 | 38.07 | 30.02 |
| Balance sheet | |||||||
| Total assets | 1,679 | 1,757 | 1,969 | 1,811 | 1,833 | 1,290 | 1,746 |
| Net worth | 1,584 | 1,664 | 1,874 | 1,716 | 1,735 | 1,166 | 1,594 |
| Total debt | 47.41 | 60.84 | 71.75 | 68.96 | 83.05 | 91.18 | 102 |
| Cash & bank | 1,469 | 1,095 | 1,374 | 923 | 755 | 868 | 421 |
| Net working capital | 502 | 501 | 677 | 475 | 414 | (232) | 159 |
| Cash flow | |||||||
| Cash from operations | 1,806 | 1,394 | 1,199 | 1,176 | 1,626 | 784 | 930 |
| Cash from investing | 374 | 55.97 | 79.24 | (7.55) | (108) | 71.35 | (18.66) |
| Cash from financing | (1,422) | (1,671) | (1,195) | (1,087) | (1,091) | (956) | (891) |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,706 | 1,603 | 1,595 | 1,486 | 1,520 | 1,434 | 1,463 | 1,462 |
| Revenue growth (YoY) | +12.3% | +11.8% | +9.1% | +1.7% | -6.2% | -4.2% | - | - |
| Other income | 21.71 | 22.80 | 16.87 | 39.28 | 15.03 | 17.94 | 19.06 | 20.40 |
| Total expenses | 1,232 | 1,124 | 1,102 | 1,052 | 1,054 | 981 | 964 | 1,007 |
| EBITDA | 473 | 480 | 493 | 434 | 465 | 453 | 498 | 454 |
| EBITDA margin | +28.0% | +30.2% | +31.2% | +29.4% | +30.9% | +31.9% | +34.3% | +31.3% |
| Depreciation | 34.16 | 39.21 | 35.08 | 36.25 | 37.19 | 37.54 | 38.37 | 41.13 |
| Interest | 0.81 | 1.03 | 0.81 | 0.97 | 0.99 | 1.02 | 1.08 | 1.11 |
| Profit before tax | 460 | 462 | 474 | 436 | 442 | 432 | 478 | 433 |
| Tax | 119 | 119 | 121 | 112 | 115 | 111 | 123 | 110 |
Financial Statements
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,706 | 1,603 | 1,595 | 1,486 | 1,520 | 1,434 | 1,463 | 1,462 |
| Revenue growth (YoY) | +12.3% | +11.8% | +9.1% | +1.7% | -6.2% | -4.2% | - | - |
| Other income | 21.71 | 22.80 | 16.87 | 39.28 | 15.03 | 17.94 | 19.06 | 20.40 |
| Total expenses | 1,232 | 1,124 | 1,102 | 1,052 | 1,054 | 981 | 964 | 1,007 |
| EBITDA | 473 | 480 | 493 | 434 | 465 | 453 | 498 | 454 |
| EBITDA margin | +28.0% | +30.2% | +31.2% | +29.4% | +30.9% | +31.9% | +34.3% | +31.3% |
| Depreciation | 34.16 | 39.21 | 35.08 | 36.25 | 37.19 | 37.54 | 38.37 | 41.13 |
| Interest | 0.81 | 1.03 | 0.81 | 0.97 | 0.99 | 1.02 | 1.08 | 1.11 |
| Profit before tax | 460 | 462 | 474 | 436 | 442 | 432 | 478 | 433 |
| Tax | 119 | 119 | 121 | 112 | 115 | 111 | 123 | 110 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 6,035 | 6,040 | 5,680 | 5,226 | 5,100 | 4,841 | 4,525 |
| Revenue growth | -0.1% | +6.3% | +8.7% | +2.5% | +5.3% | +7.0% | - |
| Other income | 89.12 | 139 | 76.52 | 53.58 | 26.26 | 30.35 | 49.24 |
| Total expenses | 4,190 | 4,082 | 3,799 | 3,690 | 3,534 | 3,332 | 3,323 |
| Employee cost | 475 | 447 | 412 | 377 | 385 | 366 | 332 |
| EBITDA | 1,845 | 1,958 | 1,881 | 1,536 | 1,566 | 1,510 | 1,202 |
| EBITDA margin | +30.6% | +32.4% | +33.1% | +29.4% | +30.7% | +31.2% | +26.6% |
| Depreciation | 146 | 163 | 172 | 175 | 177 | 182 | 198 |
| Interest | 3.79 | 4.32 | 5.00 | 4.91 | 5.89 | 7.26 | 9.62 |
| Profit before tax | 1,784 | 1,930 | 1,781 | 1,410 | 1,409 | 1,350 | 1,043 |
| Tax | 459 | 493 | 458 | 363 | 331 | 315 | 227 |
| Net profit | 1,344 | 1,436 | 1,338 | 1,055 | 1,078 | 1,036 | 816 |
| Net profit margin | +22.3% | +23.8% | +23.6% | +20.2% | +21.2% | +21.4% | +18.0% |
| EPS (βΉ) | 48.72 | 52.82 | 48.66 | 38.50 | 39.65 | 38.07 | 30.02 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 27.20 | 27.20 | 27.20 | 27.20 | 27.20 | 27.20 | 27.20 |
| Reserves & surplus | 1,557 | 1,637 | 1,847 | 1,689 | 1,707 | 1,139 | 1,567 |
| Shareholders' funds (net worth) | 1,584 | 1,664 | 1,874 | 1,716 | 1,735 | 1,166 | 1,594 |
| Secured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Unsecured loans | 47.41 | 60.84 | 71.75 | 68.96 | 83.05 | 91.18 | 102 |
| Total debt | 47.41 | 60.84 | 71.75 | 68.96 | 83.05 | 91.18 | 102 |
| Total liabilities | 1,679 | 1,757 | 1,969 | 1,811 | 1,833 | 1,290 | 1,746 |
| Assets | |||||||
| Gross block | 2,412 | 2,362 | 2,219 | 2,121 | 2,050 | 1,983 | 1,862 |
| Net block | 718 | 776 | 794 | 862 | 963 | 1,065 | 1,123 |
| Capital work in progress | 27.18 | 38.41 | 110 | 114 | 122 | 145 | 190 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 18.61 | 18.62 |
| Inventories | 376 | 377 | 296 | 335 | 357 | 336 | 297 |
| Sundry debtors | 209 | 226 | 167 | 157 | 225 | 117 | 133 |
| Cash & bank balances | 1,469 | 1,095 | 1,374 | 923 | 755 | 868 | 421 |
| Loans & advances | 177 | 64.07 | 66.23 | 132 | 146 | 52.04 | 161 |
| Total current assets | 2,231 | 1,763 | 1,904 | 1,548 | 1,483 | 1,373 | 1,012 |
| Total current liabilities | 1,729 | 1,262 | 1,227 | 1,072 | 1,068 | 1,604 | 853 |
| Net working capital | 502 | 501 | 677 | 475 | 414 | (232) | 159 |
| Total assets | 1,679 | 1,757 | 1,969 | 1,811 | 1,833 | 1,290 | 1,746 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 668 | 889 | 806 | 724 | 297 | 398 | 378 |
| Net cash from operating activities | 1,806 | 1,394 | 1,199 | 1,176 | 1,626 | 784 | 930 |
| Net cash from investing activities | 374 | 55.97 | 79.24 | (7.55) | (108) | 71.35 | (18.66) |
| Net cash from financing activities | (1,422) | (1,671) | (1,195) | (1,087) | (1,091) | (956) | (891) |
| Net change in cash | 758 | (221) | 82.93 | 81.99 | 427 | (101) | 19.82 |
| Closing cash | 1,469 | 1,095 | 1,374 | 923 | 755 | 868 | 421 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | -0.1% | +6.3% | +8.7% | +2.5% | +5.3% | +7.0% | - |
| EBITDA growth | -5.8% | +4.1% | +22.5% | -1.9% | +3.7% | +25.6% | - |
| PBT growth | -7.6% | +8.3% | +26.4% | +0.1% | +4.4% | +29.4% | -8.7% |
| Net income growth | -6.4% | +7.4% | +26.8% | -2.2% | +4.1% | +26.9% | - |
| Revenue CAGR (3Y) | +4.9% | +5.8% | +5.5% | +4.9% | +4.6% | +5.0% | +4.4% |
| EBITDA CAGR (3Y) | +6.3% | +7.7% | +7.6% | +8.5% | +8.2% | +11.1% | +8.4% |
| Profitability & leverage | |||||||
| Net income margin | +22.0% | +23.8% | +23.3% | +20.0% | +21.1% | +21.4% | +18.0% |
| Return on capital employed | +104.1% | +103.8% | +94.5% | +77.6% | +90.6% | +89.4% | +63.9% |
| Return on net worth | +81.6% | +81.2% | +73.7% | +60.7% | +74.4% | +75.0% | +53.7% |
| Debt / equity | 0.03 | 0.04 | 0.04 | 0.04 | 0.06 | 0.07 | 0.06 |
| Long-term debt / equity | 0.02 | 0.03 | 0.03 | 0.04 | 0.05 | 0.06 | 0.05 |
| Interest cover | 0.22 | 0.24 | 0.29 | 0.36 | 0.42 | 0.55 | 0.96 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 2.53 | 2.64 | 2.62 | 2.51 | 2.53 | 2.52 | 2.51 |
| Inventory turnover | 16.02 | 17.93 | 17.98 | 15.09 | 14.72 | 15.30 | 16.59 |
| Debtors turnover | 27.72 | 30.69 | 34.98 | 27.36 | 29.84 | 38.79 | 26.44 |
| EPS (βΉ) | 48.72 | 52.82 | 48.66 | 38.50 | 39.65 | 38.07 | 30.02 |
| Dividend per share (βΉ) | 58.00 | 51.00 | 58.00 | 39.00 | 40.00 | 38.00 | 28.00 |
| Book value per share (βΉ) | 58.24 | 61.19 | 68.91 | 63.11 | 63.78 | 42.86 | 58.61 |
Investments & Acquisitions by Colgate-Palmolive
Colgate-Palmolive has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include unknown.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
The company is linked to the domain caretopco.tcc.mode. | caretopco.tcc.mode | 0 | Feb 2025 | β’β’β’β’ |
Complete acquisition details for Colgate-Palmolive
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Competitors of Colgate-Palmolive
Colgate-Palmolive has 3 listed competitors in our database, 2 of them funded. They include Perfora, Salt Oral Care and Spicta.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| perforacare.com | 2021 | Gurugram, India | $8.73M | 51 | Oral hygiene products are provided by an internet-first brand. | |
| saltoralcare.com | 2023 | Mumbai, India | $1.36M | Provider of oral care and hygiene products | ||
| spicta.in | 2022 | Mumbai, India | Natural and organic oral care products are provided by Spicta. |
Detailed competitors of Colgate-Palmolive
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Beauty & Personal Care Products
3 companies that operate in the same segment as Colgate-Palmolive (Beauty & Personal Care Products) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Online platform offering a wide range of baby, kids, and maternity products | 2010 | Pune, Maharashtra, India | USD 513.39 M | USD 911.07 M | 3,752 | |
Online brand offering mens grooming products | 2015 | Gurugram, Haryana, India | USD 52.66 M | |||
Retailer of perfumes, cosmetics, skincare, and related gift set items | 2012 | Gurugram, Haryana, India | USD 60.63 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Colgate-Palmolive
Complete news archive for Colgate-Palmolive
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Colgate-Palmolive
Colgate-Palmolive is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
The primary company behind Colgate-Palmolive, Colgate-Palmolive (India) Limited, reported revenue of βΉ6,124 Cr for FY 2026, down 0% year on year.
Colgate-Palmolive is involved in the production and distribution of oral care, personal care, and household products. The company operates globally, focusing on innovative solutions for consumer needs. Sectors served include health and hygiene with a commitment to sustainability. Various brands under its portfolio cater to diverse markets. Community impact initiatives like Bright Smiles, Bright Futures are supported. Environmental preservation and diversity inclusion are prioritized in operations.
Colgate-Palmolive's top competitors include Perfora, Salt Oral Care and Spicta.
Colgate-Palmolive offers Colgate Toothpaste and Colgate Toothbrush.
Yes, Colgate-Palmolive is publicly traded on NSE under the ticker symbol COLPAL.
Colgate-Palmolive has made 1 acquisition, including unknown.
Colgate-Palmolive operates through Colgate-Palmolive (India) Limited.
The legal entities of Colgate-Palmolive currently have 9 directors, including Jacob Sebastian Madukkakuzy, Gopika Pant, Sukanya Kripalu and others.

